SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Kappac Pharma Ltd (506938)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506938 NSE: Pharmaceuticals & Drugs | Small Cap | Kappac Pharma Share Price

BSE Share Price
Not Listed

Kappac Pharma Ltd (506938)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506938 NSE: Pharmaceuticals & Drugs | Small Cap | Kappac Pharma Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹341 Cr.
Current Price
₹0
52-Week Low / High
₹113 / 113
TTM EPS
₹-0.7
TTM Sales
₹0 Cr.
Book Value per Share
₹12.6
P/E Ratio
0.00
Industry PE
46.5
Price to Book (P/B)
8.97
Price to Sales (P/S)
0.00
EV/EBITDA
-155.63
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
-0.27%
Return on Capital Employed (ROCE)
-0.27%
Return on Assets (ROA)
-0.26%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
0.00%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹8 Cr.
Equity
₹30.3 Cr.
Face Value
₹10
All Time Low / High
₹3.20 / 734.75

Kappac Pharma stock performance

Key Ratios
mw4me loader

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Kappac Pharma Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
ROCE % ⓘ-16.3%-83.1%-39%-197.3%0%-0.2%-0.3%-0.2%-0.3%-0.3%-

Growth Parameters ⓘ
Sales ⓘ3.40.8002000000
Sales YoY Gr.--77.5%-100%NANA-100%NANANANA-
Adj EPS ⓘ-2-7.9-1.83.60-0.2-0-0-0-0-0.7
YoY Gr.-NANANA-100%NANANANANA-
BVPS (₹) ⓘ13.15.13.7-0-012.510.110.110.112.612.6
Adj Net
Profit ⓘ		-0.2-0.6-0.10.30-0-0.1-0.1-0.1-0.1-2
Cash Flow from Ops. ⓘ-0.7-0.1-0-0.3-0-16.8-0.7-0.1-4.44.2-
Debt/CF from Ops. ⓘ-0-0.2-0.60-1-00-4300.1-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ-100%-100%NANA
Adj EPS ⓘNANANANA
BVPSⓘ-0.4%NA7.6%25.3%
Share Price - - - -

Key Financial Parameters ⓘ

Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
Return on
Equity % ⓘ		-13.4-79.6-38.6196.4-15.9-0.2-0.3-0.3-0.4-0.3-5.8
Op. Profit
Mgn % ⓘ		-2.3-100.500000000NAN
Net Profit
Mgn % ⓘ		-4.6-79.800000000-INF
Debt to
Equity ⓘ		0000-1.80.100.1000
Working Cap
Days ⓘ		6391,508004000000
Cash Conv.
Cycle ⓘ		-302-74100-94000000

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14
Sales3100200000
Operating Expenses ⓘ + 3201200000
Manufacturing Costs1000000000
Material Costs2000200000
Employee Cost 1100000000
Other Costs ⓘ 0001000000
Operating Profit ⓘ -0-1-0-10-0-0-0-0-0
Operating Profit Margin (%) -2.3%-100.0%--0.0%-----
Other Income ⓘ + 0001000000
Exceptional Items ⓘ 0000000000
Interest ⓘ 0000000000
Depreciation ⓘ 0000000000
Profit Before Tax ⓘ -0-1-0-00-0-0-0-0-0
Tax ⓘ -0000000000
Profit After Tax -0-1-0-00-0-0-0-0-0
PAT Margin (%) -4.5%-78.4%--0.0%-----
Adjusted EPS (₹)-2.0-7.7-1.8-3.70.0-0.2-0.0-0.0-0.0-0.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of Kappac Pharma - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14

Equity and Liabilities

Shareholders Fund + 100-0-0124242438
Share Capital ⓘ 11111124242430
Reserves ⓘ 0-0-0-1-100008
Debt +0000000300
Long Term Debt0000000000
Short Term Debt0000000300
Minority Interest0000000000
Trade Payables4341110000
Others Liabilities ⓘ 00000160000
Total Liabilities ⓘ 544111724272439

Fixed Assets

Net Fixed Assets ⓘ +1110000000
Gross Block2220000000
Accumulated Depreciation1110000000
CWIP ⓘ 0000000000
Investments ⓘ 00111411141919
Inventories0000000000
Trade Receivables0000000050
Cash Equivalents 0000000000
Others Assets ⓘ 33300131313019
Total Assets ⓘ 544111724272439

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14
Cash Flow From Operating Activity ⓘ + -1-0-0-0-0-17-1-0-44
PBT ⓘ -0-1-0-00-0-0-0-0-0
Adjustment ⓘ 0001-0-00000
Changes in Working Capital ⓘ -100-1-0-17-1-0-44
Tax Paid ⓘ 0000000000
Cash Flow From Investing Activity ⓘ + -0-00000-7-3-50
Capex -0-001000-3-50
Net Investments 000000-7000
Others ⓘ 000-1000000
Cash Flow From Financing Activity ⓘ + -0-0-0-00177310-4
Net Proceeds from Shares ⓘ 0000007000
Net Proceeds from Borrowing ⓘ 0000000000
Interest Paid ⓘ 0000000000
Dividend Paid ⓘ 0000000000
Others ⓘ -0-0-0-0017-0310-4
Net Cash Flow ⓘ -1-0-0-0-000-00-0

Financial Ratio

PARTICULARSMar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14
Ratios
ROE (%)-14.4N/AN/AN/AN/A-2.79-0.42-0.26-0.35-0.27
ROCE (%)-16.26N/AN/AN/AN/A-0.16-0.26-0.24-0.33-0.27
Asset Turnover Ratio0.430.16003.6500000
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days38.3096.80008.8000000
Inventory Days55.40000000000
Payable Days7882,945.700098.1000000

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Kappac Pharma Ltd FAQs

The current trading price of Kappac Pharma on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Kappac Pharma stood at ₹341.5 Cr

The latest P/E ratio of Kappac Pharma as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Kappac Pharma as of 31-Dec-1969 is 8.97.

The 52-week high of Kappac Pharma is ₹112.8 and the 52-week low is ₹112.8.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Kappac Pharma is ₹0.00 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Kappac Pharma Ltd is a below average quality company.

No data found

No data found

About Kappac Pharma Ltd

Kappac Pharma was incorporated in the year 1981 and has been engaged in the manufacture of pharmaceutical products. Located in the Thane district of Maharashtra, the manufacturing unit has capacity to produce capsules, tablets and syrups. The registered office is located at E-15, Nisarag Heaven Building, Dahanukar Wadi, Mahavir Nagar, Mumbai 400067.

Business areas of the company:

The company engages in the manufacture of pharmaceutical products.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×